Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001221355-26-000002

Director acquired 47,700 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kazam Joshua A · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-18 Exercise or conversion : show line 1 in the form +47,700 398,463 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-06-18 Exercise or conversion : show line 2 in the form Restricted Stock Unit −47,700 0 D
2026-06-18 Grant or award : show line 3 in the form Restricted Stock Unit +95,400 95,400 D
Loading xslF345X06/wk-form4_1782246909.xml…